CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 8-K Event Unregistered share sale · Other events
- 4 Open-market sale Director sold 7,500 shares at $4.07 ($30,525)
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 4 Grant or award Chief Financial Officer acquired 125,534 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 346,540 shares (grant or award)
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Option exercise Director acquired 45,000 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 115,000 shares at $5.22 ($600,300)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 145,473 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 17 of 45 · 895 filings